These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 9884317)
1. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver. Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829 [TBL] [Abstract][Full Text] [Related]
3. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233 [TBL] [Abstract][Full Text] [Related]
4. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver. Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770 [TBL] [Abstract][Full Text] [Related]
5. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine. Teiber JF; Hollenberg PF Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P-450 metabolism of retinals to retinoic acids. Zhang QY; Dunbar D; Kaminsky L Drug Metab Dispos; 2000 Mar; 28(3):292-7. PubMed ID: 10681373 [TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody inhibitory to human P450 2D6: a paradigm for use in combinatorial determination of individual P450 role in specific drug tissue metabolism. Gelboin HV; Krausz KW; Shou M; Gonzalez FJ; Yang TJ Pharmacogenetics; 1997 Dec; 7(6):469-77. PubMed ID: 9429232 [TBL] [Abstract][Full Text] [Related]
9. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Chang TK; Weber GF; Crespi CL; Waxman DJ Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617 [TBL] [Abstract][Full Text] [Related]
10. CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver. Dehal SS; Kupfer D Cancer Res; 1997 Aug; 57(16):3402-6. PubMed ID: 9270005 [TBL] [Abstract][Full Text] [Related]
11. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H; Shaw PM; Guengerich FP; Shimada T Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734 [TBL] [Abstract][Full Text] [Related]
12. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331 [TBL] [Abstract][Full Text] [Related]
13. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Labroo RB; Paine MF; Thummel KE; Kharasch ED Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623 [TBL] [Abstract][Full Text] [Related]
14. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091 [TBL] [Abstract][Full Text] [Related]
15. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778 [TBL] [Abstract][Full Text] [Related]
16. Role of human hepatic cytochrome P-450s in territrem A metabolism. Peng FC; Tseng HY; Tsai JC; Lin C; Doehmer J J Toxicol Environ Health A; 2003 Jul; 66(13):1237-48. PubMed ID: 12851121 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory monoclonal antibody to human cytochrome P450 2B6. Yang TJ; Krausz KW; Shou M; Yang SK; Buters JT; Gonzalez FJ; Gelboin HV Biochem Pharmacol; 1998 May; 55(10):1633-40. PubMed ID: 9633999 [TBL] [Abstract][Full Text] [Related]
18. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of (R)-(+)-pulegone and (R)-(+)-menthofuran by human liver cytochrome P-450s: evidence for formation of a furan epoxide. Khojasteh-Bakht SC; Chen W; Koenigs LL; Peter RM; Nelson SD Drug Metab Dispos; 1999 May; 27(5):574-80. PubMed ID: 10220485 [TBL] [Abstract][Full Text] [Related]
20. 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Yamazaki H; Inoue K; Mimura M; Oda Y; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Feb; 51(3):313-9. PubMed ID: 8573198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]